Market Tracker

10/24 6:05pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

11.85
Data as of Oct 24
 -0.05 / -0.42%
Today’s Change
2.62
Today|||52-Week Range
13.09
+252.68%
Year-to-Date

Today’s Trading

Previous close11.90
Today’s open11.86
Day’s range11.69 - 12.02
Volume1,979,770
Average volume (3 months)5,570,305
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+46.79%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book97.55

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp+0.08+1.42%
IPXLImpax Laboratories I...0.000.00%
THRXTheravance Inc-0.09-0.52%
--Cosmo Pharmaceutical...-11.95-6.38%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 25, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts